Krista Davis, SVP of ANI Pharmaceuticals, sold 1,730 shares of ANIP stock for $134,922.70, reducing her position by 3.39%. This follows previous sales in February and December. The stock recently traded down to $75.10, with analysts giving it a “Moderate Buy” rating and a consensus price target of $103.43.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Krista Davis Sells 1,730 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock
Krista Davis, SVP of ANI Pharmaceuticals, sold 1,730 shares of ANIP stock for $134,922.70, reducing her position by 3.39%. This follows previous sales in February and December. The stock recently traded down to $75.10, with analysts giving it a “Moderate Buy” rating and a consensus price target of $103.43.